This study aims to analyse antibiotic treatment of respiratory tract infections in ambulatory care in Belgium by: a) mapping antibiotic consumption over time and breaking down antibiotic consumption by infection type; b) discussing antibiotic treatment as recommended by Belgian guidelines; and c) reviewing the current evidence on the costeffectiveness of antibiotic treatment. IMS Health data sh...

Among key drivers of healthcare reform in Canadian society are the challenges faced by the rapid rate of technological change and its impact on organizational performance in terms of efficiency, costeffectiveness, and innovation in business and operational processes. However, despite the noted significance of the impact of technological change on healthcare organizations, the challenge of healt...

■■ Cost-Effectiveness of Pazopanib Versus Sunitinib for Renal Cancer in the United States We write to comment on a recently published study by Delea et al. in the January 2015 issue of JMCP that evaluated the costeffectiveness (CE) of sunitinib (SU) versus pazopanib (PAZ) as first-line treatment for metastatic renal cell carcinoma (mRCC) from a U.S. third-party payer perspective. This analysis ...

There is a growing interest in customer-owned generation with a particular interest in photovoltaic (PV) systems. This has resulted in a growing number of analytical studies aimed at determining their value. Two difficulties that these studies have encountered are how to select the proper evaluation perspective and which benefits and costs to include in the analysis. This paper presents a frame...

This paper presents an evaluation of battery requirements for hybrid and electric city buses. Technical specifications of recently developed lithium based batteries and vehicle simulation results are used as basis for the evaluation. The battery requirements are evaluated in terms of power and energy capacity, calendar and cycle life as well as costs. Conventional diesel, parallel and series hy...

Background: In the last decade, a number of new treatment modalities have been developed for patients with small cell lung cancer (SCLC). The clinical effects are encouraging, but little is known about the costs and cost-effectiveness of new drugs. Methods: A Markov chain model has been developed to project patient outcomes and costs for patients with advanced SCLC. All patients in the control ...

We greatly appreciate the comments of Dr. Rutte et al. regarding our recent study on the effectiveness of sexual counseling models in health care [1]. We agree with them that to find a more cost-effective alternative for standard models, such as Permission, Limited Information, Specific Suggestions, and Intensive Therapy (PLISSIT), we should perform a costeffectiveness study. We will need furth...